Critical Path Institute CEO Klaus Romero recently joined the BIO from the BAYOU Podcast for a guest appearance on the episode, “How Collaboration is Transforming Biotech and Drug Development — Inside Critical Path Institute.” This episode leads with the essential question: “What if drug development could be faster, more efficient, and centered on what matters most to patients?”
Join host Elaine Hamm, PhD, who leads this engaging discussion with Klaus in an exploration into how two decades of global collaboration have reshaped the way we bring new medicines to life. From redefining clinical endpoints to accelerating treatments for complex diseases like Alzheimer’s and tuberculosis, C-Path is leading a movement to remove bottlenecks in drug development through data, regulatory science, and partnership.
In this episode, you’ll discover:
- How C-Path’s collaborative model helps de-risk and speed up the drug development process.
- Why patient-focused science is so essential for meaningful innovation.
- How data sharing, trust-building, and regulatory transparency drive real-world impact.
Tune in to learn how C-Path is bridging science, regulation, and patient need—transforming the future of drug development through collaboration.
